|
 |
quinapril hydrochlorideThis page contains recent news articles, when available, and an overview of quinapril hydrochloride but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: quinapril hydrochloride (when available) Quinapril, an angiotensin-converting enzyme (ACE) inhibitor, is used to treat hypertension and heart failure. Like ramipril, quinapril is a prodrug that, upon deesterification, is converted to the active metabolite quinaprilat. The effect of quinapril in hypertension and in congestive heart failure (CHF) appears to result primarily from the inhibition of circulating and tissue ACE activity, thereby reducing angiotensin II formation. For the treatment of hypertension and chronic heart failure Mechanism Of Action: Quinaprilat competes with angiotensin I for binding at the angiotensin-converting enzyme, blocking the conversion of angiotensin I to angiotensin II. As angiotensin II is a vasoconstrictor and a negative-feedback mediator for renin activity, lower concentrations result in a decrease in blood pressure and stimulation of baroreceptor reflex mechanisms. Quinaprilat may also act on kininase II, an enzyme identical to ACE that degrades the vasodilator bradykinin. News Articles on Quinapril Aurobindo receives Tentative approval for Quinapril Hydrochloride & … - Jun 25, 2007 Quinapril Hydrochloride and Hydrochlorothiazide Tablets 10mg/12.5mg, 20mg/12.5mg and 20mg/25mg is the Generic equivalent of ACCURETIC TM Tablets (Pfizer ... Equity Bulls Aurobindo BP drug gets USFDA nod - Jun 27, 2007 Quinapril Hydrochloride and Hydrochlorothiazide tablets 10mg/12.5mg and 20mg/25mg are the generic equivalent of Accuretic tablets of Pfizer Pharmaceuticals ... Hindu Business Line Competitors by Product Report - Mar 29, 2008 Enalapril Maleate; Lisinopril; Quinapril Hydrochloride; Strativa Capoten (Captopril) ... Accuretic (Quinapril Hydrochloride/Hydrochlorothiazide) ... $75.00 - Revere Reports - Revere Generic ingredients: Quinapril hydrochloride, Hydrochlorothiazide - Dec 1, 2005 Accuretic combines two types of blood pressure medication. The first, quinapril hydrochloride, is an ACE (angiotensin-converting enzyme) inhibitor. ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com … Launch of Quinapril Tablets, USP and Quinapril Hydrochloride and … - Feb 28, 2007 20mg and 40mg strengths, and Quinapril Hydrochloride (HCl) and Hydrochlorothiazide (HCTZ) Tablets, 10mg/12.5mg, 20mg/12.5mg and 20mg/25mg strengths. ... Free with registration - PR Newswire - AccessMyLibrary.com Mylan Receives Approval for Quinapril Hydrochloride and … - Apr 1, 2005 PITTSBURGH, April 1 /PRNewswire-FirstCall/ -- Mylan Laboratories Inc. today announced that the US Food and Drug Administration has granted approval for ... $4.95 - PR Newswire - ECNext … Launch of Quinapril Tablets, USP and Quinapril Hydrochloride and … - Feb 28, 2007 Mylan Announces Launch of Quinapril Tablets, USP and Quinapril Hydrochloride and Hydrochlorothiazide Tablets. PR Newswire Feb 28 , 2007. PITTSBURGH, Feb. ... $4.95 - PR Newswire - ECNext Quinapril hydrochloride tablets.(NEW GENERICS) - Oct 8, 2007 The company has also received approval for quinapril hydrochloride tablets in 5-, 10-, 20-, and 40-mg strengths. As a generic version of Pfizer's Accupril ... $4.95 - Drug Topics - ECNext Quinapril hydrochloride tablets. - Oct 8, 2007 The company has also received approval for quinapril hydrochloride tablets in 5-, 10-, 20-, and 40-mg strengths. As a generic version of Pfizer's Accupril ... $9.94 - Drug Topics - Alacra Store … Launch of Quinapril Tablets, USP and Quinapril Hydrochloride and … - Feb 28, 2007 Mylan Announces Launch of Quinapril Tablets, USP and Quinapril Hydrochloride and Hydrochlorothiazide Tablets. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research New generics.(Rx) - Feb 7, 2005 Par Pharmaceutical is also shipping quinapril hydrochloride tablets in 5-, 10-, ... Quinapril hydrochloride tablets, 5, 10, 20, and 40 mg, are now available ... Free with registration - Drug Topics - AccessMyLibrary.com Competitors by Product Report - Apr 5, 2008 Mylan Inc. (MYL) Products:. Lisinopril; Quinapril Hydrochloride ... Fosinopril Sodium; IVAX Lisinopril; Lisinopril; Quinapril Hydrochloride ... $75.00 - Revere Reports - Revere Generic Games: “strategies in accupril caseâ€? - Jul 6, 2005 On January 15, 1999, Teva Pharmaceuticals USA, Inc. filed an ANDA seeking approval to market generic quinapril hydrochloride tablets with paragraph IV ... pharmabiz.com Press Release: Mylan Announces Tentative FDA Approval for Generic … - Jun 16, 2008 Article: Mylan Receives Approval for Quinapril Hydrochloride and ... ... Quinapril Hydrochloride and Hydrochlorothiazide Tablets are the generic version of ... Pay-Per-View - PR Newswire - HighBeam Research Merger and Acquisition Scenario - Sep 6, 2008 Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride ... Quinapril Hydrochloride. Angiotensin Converting Enzyme Inhibitors (ACE ... $250.00 - Revere Reports - Revere Warner-Lambert Co. v. Teva Pharmaceuticals USA, Inc., 418 F.3d 1326, ... - Aug 11, 2005 Teva moved for summary judgment that its quinapril hydrochloride formulation did not infringe composition claims 1, 4-10, or 12 of the '450 patent. ... $2.95 - U.S. Court of Appeals, Federal Circuit - VersusLaw [U] Warner Lambert Co. v. Teva Pharmaceuticals USA, Inc., No. 99-922... - Nov 29, 2007 Both are formulations of quinapril hydrochloride tablets stabilized with magnesium carbonate and lactose. This extraordinary breadth, this lack of guidance ... $2.95 - U.S. District Court, District of New... - VersusLaw Merger and Acquisition Scenario - Sep 6, 2008 Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride ... Quinapril Hydrochloride. Angiotensin Converting Enzyme Inhibitors (ACE ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 6, 2008 Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride ... Quinapril Hydrochloride. Angiotensin Converting Enzyme Inhibitors (ACE ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 6, 2008 Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride ... Quinapril Hydrochloride. Angiotensin Converting Enzyme Inhibitors (ACE ... $250.00 - Revere Reports - Revere Press Release: Actavis Launches Hydrochlorothiazide 12.5 mg Tablets... - Mar 2, 2007 Article: Mylan Receives Approval for Quinapril Hydrochloride and ... ... Quinapril Hydrochloride and Hydrochlorothiazide Tablets are the generic version of ... Pay-Per-View - PR Newswire - HighBeam Research Article: PFIZER INC - Injunction. - PR Newswire UK Disclose |... - Mar 30, 2005 Drug Administration granted approval for Teva to produce generic quinapril hydrochloride in tablets of 5, 10, 20 and 40 milligrams ... ... Pay-Per-View - PR Newswire UK Disclose - HighBeam Research Competitors by Product Report - Dec 20, 2008 Pfizer Inc. (PFE) Products:. Accupril (Quinapril Hydrochloride) ... Accuretic (Quinapril Hydrochloride/Hydrochlorothiazide); Apixaban; CP-800569 ... $75.00 - Revere Reports - Revere Company Profile Report - Sep 30, 2006 Andrx Pharmaceuticals Quinapril Hydrochloride; Andrx Pharmaceuticals Benazepril Hydrochloride. Angiotensin Converting Enzyme Inhibitors (ACE ... $50.00 - Revere Reports - Revere Ranbaxy settles worldwide patent litigations with Pfizer - Jun 19, 2008 US) and Viagra (in Ecuador) and all patent litigation relating to generic formulation of Quinapril hydrochloride in the US and Sildenafil in Ecuador. Hindu Business Line Berkshire Hathaway Inc acquires a minority stake in Sanofi-Aventis SA... - Aug 15, 2006 PFE ) Products: Accupril (Quinapril Hydrochloride) Sanofi-Aventis SA (ADR) ( SNY ) Products: Delix…Products: Diovan (Valsartan) Sandoz Irbesartan ... Pay-Per-View - deals - Alacra Store Drug/Medical Device - Sep 30, 2006 Andrx Pharmaceuticals Quinapril Hydrochloride, Hypertension, Coughing, Dizziness, Fatigue, Diarrhea, Approved. Angiotensin Converting Enzyme Inhibitors (ACE ... $70.00 - Revere Reports - Revere US court upholds bar against Ranbaxy blood pressure drug - Nov 24, 2005 The patent for the key ingredient quinapril hydrochloride expires in August 2007. According to analysts tracking the sector, "It is unlikely that there ... Hindu Business Line India's Aurobindo Pharma gets 'tentative' US FDA approval for … - Jun 26, 2007 Administration (FDA) for anti-hypertension drugs Quinapril Hydrochloride and Hydrochlorothiazide tablets in the strengths of 10mg/12.5mg, and 20mg/25mg. ... Forbes Aurobindo Pharma receives USFDA approval for terbinafine HCL tablets - Jul 4, 2007 Recently the company received a tentative approval from the US FDA for Quinapril hydrochloride and Hydrochlorothiazide tablets 10mg/12.5mg, and 20mg/25mg. ... Myiris.com Article: Patent ruling favors Pfizer - The Record (Bergen County, NJ)... - Nov 23, 2005 The patent, for the key ingredient quinapril hydrochloride, expires in August 2007. Pfizer has said it would seek a court ruling forcing Teva and Ranbaxy to ... Pay-Per-View - The Record - HighBeam Research Schwarz Pharma, Inc. v. Paddock Laboratories, Inc., 429 F.Supp.2d... - Apr 18, 2006 ...the amount of magnesium carbonate in the drug product greatly outweighs the amount of quinapril hydrochloride. Pejic Decl. 3d Ex. 1, col. ... $2.95 - U.S. District Court, District of... - VersusLaw Competitors by Product Report - Sep 13, 2008 Pfizer Inc. (PFE) Products:. Accupril (Quinapril Hydrochloride); Test New Tradename. Pharmacopeia, Inc. (PCOP) Products:. PS460644 ... $75.00 - Revere Reports - Revere Diabetes; Research from Singapore, Taiwan and Denmark in diabetes … - Aug 28, 2006 Gene Expression, Genetics, Genomics, Glucose Uptake, Insulin, Metabolism, Pharmaceuticals, Quinapril Hydrochloride, Type 2 Diabetes, Vasodilation. ... Pay-Per-View - OBGYN & Reproduction Week - Factiva, from Dow Jones Loislaw Federal District Court Opinions - SCHWARZ PHARMA, INC. v. … - Jan 4, 2005 Teva drug formulation containing the active ingredient quinapril hydrochloride infringed the `450 patent (the "Quinapril Action"), Warner-Lambert Co. v. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Generics makers keep new products coming. - Sep 17, 2007 Teva Pharmaceutical Industries Ltd. It has been given approval of generic Accupril (Pfizer Inc.). Teva's quinapril hydrochloride tablets are available in ... $20.00 - Chain Drug Review - Alacra Store Merger and Acquisition Scenario - Sep 6, 2008 Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride; Trandolapril. Target. Cetirizine Hydrochloride; Metroprolol Tartrate; Atenolol ... $250.00 - Revere Reports - Revere New generics.(Rx) - Jun 20, 2005 Quinapril hydrochloride and hydrochlorothiazide tablets, available in 10 mg/12.5 mg, 20 mg/12.5 mg, and 20 mg/25 mg strengths, provide a generic alternative ... Free with registration - Drug Topics - AccessMyLibrary.com Merger and Acquisition Scenario - Sep 6, 2008 Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride; Trandolapril. Target. APD791 (5-HT2A Serotonin Receptor Agonist) ... $250.00 - Revere Reports - Revere New generics.(drug approvals)(Brief Article) - May 2, 2005 Quinapril hydrochloride and hydrochlorothiazide tablets, available in 10 mg/12.5 mg, 20 mg/12.5 mg, and 20 mg/25 mg strengths, provide a generic alternative ... Free with registration - Drug Topics - AccessMyLibrary.com Merger and Acquisition Scenario - Sep 13, 2008 Target (Total: 68). Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride; Trandolapril. Buyer. Hi-Volume Pumping Chamber Set ... $250.00 - Revere Reports - Revere Generics makers keep new products coming.(RX/GENERICS)(Statistical … - Sep 17, 2007 Teva's quinapril hydrochloride tablets are available in several strengths. RX/GENERICS Top 400 Multisource Generics LABELER DRUG NAME TOTAL TRx DOLLARS Teva ... Free with registration - Chain Drug Review - AccessMyLibrary.com Generic Drugs; Pharma company receives final approval to market … - Jan 18, 2005 ...has received final approval from the US Food and Drug Administration for its abbreviated new drug application for quinapril hydrochloride (HCl) tablets. ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Merger and Acquisition Scenario - Nov 29, 2008 Buyer (Total: 71). Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride; Trandolapril. Target (Total: 5). XP19986 (R-Baclofen Prodrug) ... $250.00 - Revere Reports - Revere Teva Pharmaceutical (TEVA) Receives FDA Approval for Generic Accupril - Aug 27, 2007 ...to market its generic version of Pfizer's (NYSE: PFE) hypertension treatment Accupril (Quinapril Hydrochloride) Tablets, 5 mg, 10 mg, 20 mg and 40 mg. ... StreetInsider.com - StreetInsider.com (subscription) Merger and Acquisition Scenario - Sep 6, 2008 Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride; Trandolapril. Target. Twinject Epinephrine Auto-Injector; Rondec Syrup/Rondec Oral ... $250.00 - Revere Reports - Revere Generic Drugs; Pharma company receives final approval to market … - Jan 23, 2005 ...has received final approval from the US Food and Drug Administration for its abbreviated new drug application for quinapril hydrochloride (HCl) tablets. ... Pay-Per-View - Heart Disease Weekly - Factiva, from Dow Jones Merger and Acquisition Scenario - Sep 6, 2008 Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride; Trandolapril. Target. EUR-1000 (Long Acting Propranolol); Zentase (Pancreatic ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 13, 2008 Buyer (Total: 237). Vistaril (Hydroxyzine Pamoate); Accupril (Quinapril Hydrochloride); Test New Tradename; Fragmin (Dalteparin Sodium) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 15, 2008 Target (Total: 71). Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride; Trandolapril. Buyer. Directed Biosynthesis Program; Natural ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 6, 2008 Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride; Trandolapril. Target. Qnexa (Phentermine/Topiramate); Evamist (Estradiol ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Dec 20, 2008 Target (Total: 71). Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride; Trandolapril. Buyer. Duramed AmniScreen Home Detection Liner ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 22, 2008 Target (Total: 71). Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride; Trandolapril. Buyer. n/a. Target ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 6, 2008 Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride; Trandolapril. Target. R343 (Inhaled Syk Kinase Inhibitor); R788 (Oral Syk Kinase ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Dec 27, 2008 Target (Total: 71). Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride; Trandolapril. Buyer. Alpharma Animal Health Division. Target ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Dec 20, 2008 Vistaril (Hydroxyzine Pamoate); Accupril (Quinapril Hydrochloride); Fragmin (Dalteparin Sodium); Calan/Calan SR (Verapamil Hydrochloride) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 6, 2008 Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride; Trandolapril. Target. Cyproheptadine HCl; Fluticasone Propionate Nasal Spray ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 13, 2008 Buyer (Total: 68). Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride; Trandolapril. Target (Total: 9) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 6, 2008 Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride; Trandolapril. Target. EW-A-401 (Zinc Finger DNA-Binding Proteins) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 6, 2008 Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride; Trandolapril. Target. rFactor XIII; Interleukin 22 Receptor Subunit Alpha ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 6, 2008 Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride; Trandolapril. Target. rHuPH20 (Recombinant Human Hyaluronidase Enzyme); HTI-101 ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Dec 13, 2008 Buyer (Total: 71). Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride; Trandolapril. Target (Total: 8) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Aug 2, 2008 Buyer (Total: 66). Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride; Ramipril. Target (Total: 10) ... $250.00 - Revere Reports - Revere Accuretic.(Drug overview) - Jan 22, 2007 The first, quinapril hydrochloride, is an ACE (angiotensin-converting enzyme) inhibitor. It works by preventing a chemical in your blood called angiotensin ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com Generic Drugs; Pharma company receives final approval to market … - Jan 21, 2005 ...has received final approval from the US Food and Drug Administration for its abbreviated new drug application for quinapril hydrochloride (HCl) tablets. ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Merger and Acquisition Scenario - Sep 6, 2008 Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride; Trandolapril. Target. Chore Boy; Cutex; Denorex; Prell ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 13, 2008 Target (Total: 68). Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride; Trandolapril. Buyer. Quantitative Diagnostics Laboratories ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 1, 2008 Buyer (Total: 71). Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride; Trandolapril. Target (Total: 93) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 15, 2008 Target (Total: 71). Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride; Trandolapril. Buyer. T5000 Biosensor System. Target ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 1, 2008 Target (Total: 71). Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride; Trandolapril. Buyer. Selsun Blue/Selsun Salon (Selenium ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jul 12, 2008 Buyer (Total: 65). Fexofenadine Hydrochloride; Amlodipine Besylate; Quinapril Hydrochloride; Ramipril. Target (Total: 12) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Dec 27, 2008 Vistaril (Hydroxyzine Pamoate); Accupril (Quinapril Hydrochloride); Fragmin (Dalteparin Sodium); Calan/Calan SR (Verapamil Hydrochloride) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Dec 13, 2008 Vistaril (Hydroxyzine Pamoate); Accupril (Quinapril Hydrochloride); Fragmin (Dalteparin Sodium); Calan/Calan SR (Verapamil Hydrochloride) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 22, 2008 Vistaril (Hydroxyzine Pamoate); Accupril (Quinapril Hydrochloride); Fragmin (Dalteparin Sodium); Calan/Calan SR (Verapamil Hydrochloride) ... $250.00 - Revere Reports - Revere Mylan launches generic BP drugs - Mar 1, 2007 Southpointe-based Mylan also launched quinapril hydrochloride and hydrochlorothiazide tablets in several strengths. Quinapril is in a group of blood ... $2.95 - Observer-Reporter - NewsBank Merger and Acquisition Scenario - Nov 1, 2008 Buyer (Total: 236). Vistaril (Hydroxyzine Pamoate); Accupril (Quinapril Hydrochloride); Fragmin (Dalteparin Sodium); Procardia XL (Nifedipine) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 13, 2008 Target (Total: 237). Vistaril (Hydroxyzine Pamoate); Accupril (Quinapril Hydrochloride); Test New Tradename; Fragmin (Dalteparin Sodium) ... $250.00 - Revere Reports - Revere Competitors by Product Report - Oct 18, 2008 Accuretic (Quinapril Hydrochloride/Hydrochlorothiazide); Apixaban; CP-800569; Encysive Oral Thelin (Sitaxsentan); Encysive Pharmaceuticals Intravenous ... $75.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 29, 2008 Buyer (Total: 236). Vistaril (Hydroxyzine Pamoate); Accupril (Quinapril Hydrochloride); Fragmin (Dalteparin Sodium); Procardia XL (Nifedipine) ... $250.00 - Revere Reports - Revere Competitors by Product Report - Dec 20, 2008 Accuretic (Quinapril Hydrochloride/Hydrochlorothiazide); Apixaban; CP-800569; Encysive Oral Thelin (Sitaxsentan); Encysive Pharmaceuticals Intravenous ... $75.00 - Revere Reports - Revere Loislaw Federal District Court Opinions - PFIZER INC. v. TEVA … - Sep 25, 2007 Warner-Lambert accuses Ranbaxy's quinapril hydrochloride product, which was sold by Teva from December, 2004, until March, 2005, of infringing the `450 ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Tevaçš„Accupril仿制è?¯èŽ·FDA批准 - Aug 27, 2007 Ltd.(TEVA)周一宣布，食å“?å’Œè?¯å“?管ç?†å±€(FDA)æ£å¼?批准了该公å?¸çš„简å¼?æ–°è?¯ç”³è¯·ï¼Œå‡†è®¸ 其对辉瑞公å?¸çš„é™?压è?¯Accupril(Quinapril Hydrochloride)的仿制版本上市。 ... 新浪网 Lickenfelt v. Astrue, No. 07-0958 (WDPa. 05/30/2008) - May 30, 2008 ...[116], *fn3 Accupril is a brand name for quinapril hydrochloride and prescribed to patients with mild to severe hypertension. ... $2.95 - U.S. District Court, Western District... - VersusLaw Brand Names/Synonyms: quinapril hydrochloride is also known by the following brand names and/or synonymsAccupril; Accuprin; Accupro; Acequin; Acuitel; Korec; Quinapril; Quinapril Hcl; Quinapril Hydrochloride; Quinapril Hydrochloride: Accupril; Quinaprilum [Latin]; Quinazil Drug Category: quinapril hydrochloride is categorized under the following by the FDA: Antihypertensive Agents; Angiotensin-converting Enzyme Inhibitors; ATC:C09AA06 Dosage Forms: Tablets Absorption: Following oral administration, peak plasma quinapril concentrations are observed within one hour. Based on recovery of quinapril and its metabolites in urine, the extent of absorption is at least 60%. The rate and extent of quinapril absorption are diminished moderately (approximately 25-30%) when ACCUPRIL tablets are administered during a high-fat meal. Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 2-[2-(1-ethoxycarbonyl-3-phenyl-propyl)aminopropanoyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |